Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,209,424 papers from all fields of science
Search
Sign In
Create Free Account
SNK 860
Known as:
SNK-860
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
fidarestat
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Differential Effects of High Glucose and Methylglyoxal on Viability and Polyol Metabolism in Immortalized Adult Mouse Schwann Cells
K. Sango
,
H. Yanagisawa
,
Koichi Kato
,
N. Kato
,
H. Hirooka
,
K. Watabe
2008
Corpus ID: 14519419
Cultured Schwann cells under exposure to high glucose and methylglyoxal (MG) have been individually em- ployed for studying…
Expand
Highly Cited
2006
Highly Cited
2006
The role of polyol pathway in high glucose-induced endothelial cell damages.
T. Oyama
,
Yoh Miyasita
,
Husako Watanabe
,
K. Shirai
Diabetes Research and Clinical Practice
2006
Corpus ID: 36394975
2004
2004
Effects of a Novel Aldose Reductase Inhibitor, Fidarestat (SNK-860), on Vibration Perception Threshold and Subjective Symptoms in Patients with Diabetic Polyneuropathy
N. Hotta
,
K. Yasuda
,
+9 authors
Kouichi Mori
Clinical drug investigation
2004
Corpus ID: 24474098
ObjectiveTo evaluate the effects of fidarestat (SNK-860) on vibration perception threshold, as measured by C64 quantitative…
Expand
2004
2004
Suppression of 3-deoxyglucosone and heparin-binding epidermal growth factor-like growth factor mRNA expression by an aldose reductase inhibitor in rat vascular smooth muscle cells.
Weiguo Li
,
Y. Hamada
,
+9 authors
J. Nakamura
Biochemical and Biophysical Research…
2004
Corpus ID: 21463568
1999
1999
Effect of aldose reductase inhibitors on glucose‐ induced changes in sorbitol and myo‐inositol metabolism in human neutrophils
K. Suzuki
,
T. Kawamura
,
+4 authors
N. Hotta
Diabetic Medicine
1999
Corpus ID: 8611223
Aim To investigate the influence of glucose and the efficacy of two different aldose reductase (AR) inhibitors, epalrestat and…
Expand
1996
1996
SNK-860 : SYMPTOMATIC ANTIDIABETIC, ALDOSE REDUCTASE INHIBITOR
N. Mealy
,
J. Castaǹer
1996
Corpus ID: 78490105
1995
1995
Effect of an aldose reductase inhibitor, SNK‐860, on deficits in the electroretinogram of diabetic rats
N. Hotta
,
N. Koh
,
+8 authors
Aloj Et
Experimental Physiology
1995
Corpus ID: 44772623
To determine the effect of an aldose reductase inhibitor, SNK‐860, on the worsening of the electroretinogram (ERG) during a…
Expand
1995
1995
Effects of Glucose and SNK‐860, an Aldose Reductase Inhibitor, on the Polyol Pathway and Chemiluminescence Response of Human Neutrophils in vitro
Tetsuya Kawamura
,
K. Suzuki
,
H. Matsumae
,
T. Sano
,
Nobuo Sakamoto
,
N. Hotta
Diabetic Medicine
1995
Corpus ID: 42206943
An in vitro incubation study was conducted to investigate whether increased activity of the polyol pathway in human neutrophils…
Expand
1994
1994
Synthesis and aldose reductase inhibitory activity of 2-substituted-6-fluoro-2,3-dihydrospiro [4H-1-benzopyran-4, 4'-imidazolidine]-2',5'-diones.
T. Yamaguchi
,
K. Miura
,
+7 authors
M. Kurono
Arzneimittel-Forschung
1994
Corpus ID: 6254275
Optically active and racemic 2-substituted-6-fluoro-2,3-dihydrospiro[4H-1-benzopyran-4, 4'-imidazolidine]-2',5'-diones were…
Expand
1994
1994
Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro-[chroman-4,4′-imidazolidine]-2-carboxamide (SNK-860), on peripheral neuropathy in streptozotocin…
N. Kato
,
K. Mizuno
,
A. Matsubara
,
K. Nakano
,
M. Kurono
,
S. Yagihashi
1994
Corpus ID: 72839964
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE